Cargando…
Proton pump inhibitors affect capecitabine efficacy in patients with stage II–III colorectal cancer: a multicenter retrospective study
The association between capecitabine efficacy and proton pump inhibitors (PPIs) is controversial. Here, we determined whether co-administration of PPIs affects the real-world effectiveness of capecitabine. This retrospective observational study included consecutive patients with stage II–III colorec...
Autores principales: | Kitazume, Yoshiko, Kawazoe, Hitoshi, Uozumi, Ryuji, Yoshizawa, Tomoe, Iihara, Hirotoshi, Fujii, Hironori, Takahashi, Masaya, Arai, Takahiro, Murachi, Yasushi, Sato, Yumiko, Mikami, Takahiro, Hashiguchi, Koji, Yamazaki, Tomoko, Takahashi, Katsuyuki, Fujita, Yukiyoshi, Hosokawa, Yuki, Morozumi, Issei, Tsuchiya, Masami, Yokoyama, Atsushi, Hashimoto, Hironobu, Yamaguchi, Masakazu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9023444/ https://www.ncbi.nlm.nih.gov/pubmed/35449143 http://dx.doi.org/10.1038/s41598-022-10008-2 |
Ejemplares similares
-
Association between the Co-administration of Histamine H(2) Receptor Antagonists and the Effectiveness of Capecitabine in Patients with Colorectal Cancer: Propensity Score Analysis
por: Yamazaki, Tomoko, et al.
Publicado: (2022) -
Efficacy and safety of 5 mg olanzapine for nausea and vomiting management in cancer patients receiving carboplatin: integrated study of three prospective multicenter phase II trials
por: Yamamoto, Senri, et al.
Publicado: (2021) -
Effects of adding a neurokinin-1 receptor antagonist to 5 mg olanzapine, a 5-hydroxytryptamine-3 receptor antagonist, and dexamethasone for preventing carboplatin-induced nausea and vomiting: a propensity score-matched analysis
por: Yamamoto, Senri, et al.
Publicado: (2022) -
Study protocol for a double-blind, comparative, randomised Japanese trial of triplet standard antiemetic therapies with or without 5 mg olanzapine to prevent chemotherapy-induced nausea and vomiting for patients with breast cancer treated with an anthracycline/cyclophosphamide regimen (JTOP-B)
por: Ozeki, Rie, et al.
Publicado: (2022) -
Low‐Dose Olanzapine Plus Granisetron and Dexamethasone for Carboplatin‐Induced Nausea and Vomiting in Patients with Thoracic Malignancies: A Prospective Multicenter Phase II Trial
por: Sakai, Chizuru, et al.
Publicado: (2021)